In Section A, members will acquire distinct doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Extra individuals are going to be enrolled on the recognized monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 will probably be supplied as "increase-on" therapy. In https://abbv-744therapeuticpotent69024.blog2freedom.com/32040743/5-simple-statements-about-abbv-744-clinical-trial-phase-1-results-explained